MeiraGTx Holdings Management
Management criteria checks 3/4
MeiraGTx Holdings' CEO is Alexandria Forbes, appointed in Mar 2015, has a tenure of 9.67 years. total yearly compensation is $6.34M, comprised of 10.2% salary and 89.8% bonuses, including company stock and options. directly owns 1.79% of the company’s shares, worth $8.30M. The average tenure of the management team and the board of directors is 5.5 years and 9.4 years respectively.
Key information
Alexandria Forbes
Chief executive officer
US$6.3m
Total compensation
| CEO salary percentage | 10.2% |
| CEO tenure | 9.7yrs |
| CEO ownership | 1.8% |
| Management average tenure | 5.5yrs |
| Board average tenure | 9.4yrs |
Recent management updates
Recent updates
Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results
Nov 15
MeiraGTx: Positive PD Data Moves Needle Forward For Regulatory Meetings
Oct 15MeiraGTx: A Very Attractive Longer-Term Play, With Potential Near-Term Catalysts
Jul 15MeiraGTx Holdings (NASDAQ:MGTX) Has Debt But No Earnings; Should You Worry?
Jun 19MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met
Feb 15Does MeiraGTx Holdings (NASDAQ:MGTX) Have A Healthy Balance Sheet?
Sep 08Calculating The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX)
Apr 11MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Reducing Their Forecasts For This Year
Mar 16MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are More Bearish Than They Used To Be
Nov 16MeiraGTx GAAP EPS of -$0.76, revenue of $10.76M
Aug 11MeiraGTx inks $100M debt agreement backed by manufacturing facilities
Aug 03MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans
Apr 29Analysts' Revenue Estimates For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher
Mar 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$88m |
| Jun 30 2024 | n/a | n/a | -US$93m |
| Mar 31 2024 | n/a | n/a | -US$74m |
| Dec 31 2023 | US$6m | US$648k | -US$84m |
| Sep 30 2023 | n/a | n/a | -US$132m |
| Jun 30 2023 | n/a | n/a | -US$125m |
| Mar 31 2023 | n/a | n/a | -US$129m |
| Dec 31 2022 | US$8m | US$580k | -US$130m |
| Sep 30 2022 | n/a | n/a | -US$112m |
| Jun 30 2022 | n/a | n/a | -US$101m |
| Mar 31 2022 | n/a | n/a | -US$87m |
| Dec 31 2021 | US$6m | US$580k | -US$80m |
| Sep 30 2021 | n/a | n/a | -US$80m |
| Jun 30 2021 | n/a | n/a | -US$61m |
| Mar 31 2021 | n/a | n/a | -US$66m |
| Dec 31 2020 | US$8m | US$602k | -US$58m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$57m |
| Mar 31 2020 | n/a | n/a | -US$52m |
| Dec 31 2019 | US$8m | US$580k | -US$55m |
| Sep 30 2019 | n/a | n/a | -US$70m |
| Jun 30 2019 | n/a | n/a | -US$75m |
| Mar 31 2019 | n/a | n/a | -US$86m |
| Dec 31 2018 | US$23m | US$555k | -US$85m |
| Sep 30 2018 | n/a | n/a | -US$73m |
| Jun 30 2018 | n/a | n/a | -US$66m |
| Mar 31 2018 | n/a | n/a | -US$42m |
| Dec 31 2017 | US$1m | US$450k | -US$32m |
Compensation vs Market: Alexandria's total compensation ($USD6.34M) is above average for companies of similar size in the US market ($USD2.24M).
Compensation vs Earnings: Alexandria's compensation has been consistent with company performance over the past year.
CEO
Alexandria Forbes (59 yo)
9.7yrs
Tenure
US$6,336,832
Compensation
Dr. Alexandria Forbes, Ph.D. serves as the Chief Executive Officer, Director and President at MeiraGTx Holdings plc (formerly known as MeiraGTx Limited) since March 2015. Prior to joining MeiraGTx, Dr. For...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 9.7yrs | US$6.34m | 1.79% $ 8.3m | |
| COO & CFO | 9.7yrs | US$4.98m | 1.19% $ 5.5m | |
| Chief Development Officer | 9.6yrs | US$2.50m | 0.72% $ 3.3m | |
| General Counsel & Secretary | 5.3yrs | no data | 0.019% $ 89.6k | |
| Head of Clinical Ophthalmology | 3.8yrs | no data | no data | |
| Senior Vice President of Global Integration | no data | no data | no data | |
| Senior Vice President of Risk & Internal Controls | 5.6yrs | no data | no data | |
| Senior Vice President of Manufacturing & Supply Chain | 5.3yrs | no data | no data | |
| Chief Medical Officer | 4.3yrs | US$4.05m | 0.11% $ 531.1k |
5.5yrs
Average Tenure
58yo
Average Age
Experienced Management: MGTX's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 9.7yrs | US$6.34m | 1.79% $ 8.3m | |
| Member of Scientific Advisory Board | no data | US$149.82k | 0% $ 0 | |
| Independent Director & Member of Scientific Advisory Board | 9.4yrs | US$347.73k | 0% $ 0 | |
| Independent Chairman of the Board | 9.4yrs | US$538.84k | 0.064% $ 296.0k | |
| Independent Director | 5.5yrs | US$395.76k | 0.0064% $ 29.6k | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 9.4yrs | US$352.73k | 0.016% $ 76.2k | |
| Director | 7.1yrs | US$264.23k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
9.4yrs
Average Tenure
68yo
Average Age
Experienced Board: MGTX's board of directors are considered experienced (9.4 years average tenure).